Delivering Novel Therapies in the 21St Century Conference Report Held on 24 – 25 October 2018
Part of the conference series Breakthrough science and technologies Transforming our future Delivering novel therapies in the 21st century Conference report Held on 24 – 25 October 2018 Supported by AstraZeneca Delivering novel therapies in the 21st century – Conference report 1 Introduction On 24 – 25 October 2018, the Royal Society and the Academy of Medical Sciences hosted a conference on novel medical therapies. The scientific programme for this meeting was developed by Steve Rees (Vice-President Discovery Biology, AstraZeneca), Professor Molly Stevens FREng (Professor of Biomedical Materials and Regenerative Medicine and Research Director for Biomedical Material Science, Imperial College London), and Sir John Skehel FMedSci FRS (Vice-President and Biological Secretary, the Royal Society). Image: Conference attendees networking. Presentations and discussions outlined recent scientific organised through the Royal Society’s Science and Industry advances in therapeutic modalities and delivery, the programme which demonstrates our commitment to integrate infrastructure required to develop novel treatments, and the science and industry at the Society, promote science and its implications of these advances for policy and healthcare value, build relationships and foster translation. delivery. The conference brought together scientists, technologists and experts from across academia, industry, The Academy’s FORUM programme brings together the NHS and public health, to discuss current challenges in industry, academia and the NHS, and the charity, regulatory human medicine, what future medicines will look like and and wider healthcare sectors. It provides an independent how we can prepare for them. platform for leaders from across the life sciences sector to discuss scientific opportunities, technology trends, This conference, supported by AstraZeneca, forms part of a translational challenges and strategic choices in healthcare.
[Show full text]